Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Presence of GAD-antibodies during gestational diabetes predicts type 1 diabetes.

Nilsson, Charlotta ; Ursing, Dag ; Törn, Carina LU ; Åberg, Anders E LU and Landin-Olsson, Mona LU (2007) In Diabetes Care 30(8). p.1968-1971
Abstract
OBJECTIVE - we sought to study the frequency of P-cell-specific autoantibody markers in women with gestational diabetes mellitus (GDM) and to follow these women to estimate the risk of later development of type I diabetes. RESEARCH DESIGN AND METHODS - Of 385 pregnant women with GDM during 1995-2005 in the district of Lund, 24 (6%) women were found positive for at least one of the following: islet cell antibody (ICA), GAD antibody (GADA), or tyrosine phosphatase antibody(IA-2A). The women were followed and autoantibodies reanalyzed. Those who had not developed diabetes did an oral glucose tolerance test. The frequencies of known risk factors; for GD were compared in women with GDM with and without pancreatic autoantibodies. RESULTS - Among... (More)
OBJECTIVE - we sought to study the frequency of P-cell-specific autoantibody markers in women with gestational diabetes mellitus (GDM) and to follow these women to estimate the risk of later development of type I diabetes. RESEARCH DESIGN AND METHODS - Of 385 pregnant women with GDM during 1995-2005 in the district of Lund, 24 (6%) women were found positive for at least one of the following: islet cell antibody (ICA), GAD antibody (GADA), or tyrosine phosphatase antibody(IA-2A). The women were followed and autoantibodies reanalyzed. Those who had not developed diabetes did an oral glucose tolerance test. The frequencies of known risk factors; for GD were compared in women with GDM with and without pancreatic autoantibodies. RESULTS - Among the autoantibody-positive women, 50% had developed type I diabetes compared with none among the GDM control subjects (P = 0. 00 1), 2 1 % had impaired fasting glucose or impaired glucose tolerance compared with 12.5% among control subjects (P = 0.3), and none had developed type 2 diabetes compared with 12.5% among control subjects (P 0.1). CONCLUSIONS - Autoantibody screening in pregnant women with GDM and follow-up after delivery should be considered for early recognition of type I diabetes. (Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Diabetes Care
volume
30
issue
8
pages
1968 - 1971
publisher
American Diabetes Association
external identifiers
  • wos:000248570200005
  • scopus:34547656275
ISSN
1935-5548
DOI
10.2337/dc07-0157
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Department of Obstetrics and Gynaecology (Lund) (013018000), Diabetes and Endocrinology (013241530), Medicine (Lund) (013230025), Section I-II (013230011), Pediatrics/Urology/Gynecology/Endocrinology (013240400), Division V (013230900), Diabetes and Celiac Unit (013241540)
id
a627612a-8d39-48e9-a959-a19a407a2a39 (old id 168151)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17519433&dopt=Abstract
date added to LUP
2016-04-01 16:36:52
date last changed
2024-02-26 20:56:08
@article{a627612a-8d39-48e9-a959-a19a407a2a39,
  abstract     = {{OBJECTIVE - we sought to study the frequency of P-cell-specific autoantibody markers in women with gestational diabetes mellitus (GDM) and to follow these women to estimate the risk of later development of type I diabetes. RESEARCH DESIGN AND METHODS - Of 385 pregnant women with GDM during 1995-2005 in the district of Lund, 24 (6%) women were found positive for at least one of the following: islet cell antibody (ICA), GAD antibody (GADA), or tyrosine phosphatase antibody(IA-2A). The women were followed and autoantibodies reanalyzed. Those who had not developed diabetes did an oral glucose tolerance test. The frequencies of known risk factors; for GD were compared in women with GDM with and without pancreatic autoantibodies. RESULTS - Among the autoantibody-positive women, 50% had developed type I diabetes compared with none among the GDM control subjects (P = 0. 00 1), 2 1 % had impaired fasting glucose or impaired glucose tolerance compared with 12.5% among control subjects (P = 0.3), and none had developed type 2 diabetes compared with 12.5% among control subjects (P 0.1). CONCLUSIONS - Autoantibody screening in pregnant women with GDM and follow-up after delivery should be considered for early recognition of type I diabetes.}},
  author       = {{Nilsson, Charlotta and Ursing, Dag and Törn, Carina and Åberg, Anders E and Landin-Olsson, Mona}},
  issn         = {{1935-5548}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{1968--1971}},
  publisher    = {{American Diabetes Association}},
  series       = {{Diabetes Care}},
  title        = {{Presence of GAD-antibodies during gestational diabetes predicts type 1 diabetes.}},
  url          = {{http://dx.doi.org/10.2337/dc07-0157}},
  doi          = {{10.2337/dc07-0157}},
  volume       = {{30}},
  year         = {{2007}},
}